The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott | Common | 002824100 | 18,209 | 167,600 | SH | SOLE | 167,600 | 0 | 0 | ||
Abbvie | Common | 00287Y109 | 34,231 | 223,500 | SH | SOLE | 223,500 | 0 | 0 | ||
Allstate | Common | 020002101 | 34,128 | 269,300 | SH | SOLE | 269,300 | 0 | 0 | ||
Amerco | Common | 023586100 | 36,084 | 75,455 | SH | SOLE | 75,455 | 0 | 0 | ||
Apple | Common | 037833100 | 18,785 | 137,400 | SH | SOLE | 137,400 | 0 | 0 | ||
Ashland | Common | 044209104 | 2,576 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
Avista | Common | 05379B107 | 8,919 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
Amryt | Common | 03217L106 | 2,203 | 315,182 | SH | SOLE | 315,182 | 0 | 0 | ||
CMS Energy | Common | 125896100 | 30,273 | 448,500 | SH | SOLE | 448,500 | 0 | 0 | ||
Acorda Theraputics | Cv 6.0% | 00484MAB2 | 3,700 | 5,000,000 | PRN | SOLE | 5,000,000 | 0 | 0 | ||
Accelerate Diagnostic | Cv 2.5% | 00430HAB8 | 2,040 | 3,000,000 | PRN | SOLE | 3,000,000 | 0 | 0 | ||
Duke Energy | Common | 26441C204 | 30,683 | 286,200 | SH | SOLE | 286,200 | 0 | 0 | ||
EDAP | Common | 268311107 | 3,846 | 565,652 | SH | SOLE | 565,652 | 0 | 0 | ||
Fate Theraputics | Common | 31189P102 | 1,412 | 57,000 | SH | SOLE | 57,000 | 0 | 0 | ||
AT & T | Common | 00206R102 | 19,325 | 922,000 | SH | SOLE | 922,000 | 0 | 0 | ||
Warner Bros. Discovery | Common | 934423104 | 2,986 | 222,558 | SH | SOLE | 222,558 | 0 | 0 | ||
Nextera Energy | Common | 302571104 | 35,631 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | ||
Novavax | Cv 3.75% | 670002AB0 | 600 | 600,000 | PRN | SOLE | 600,000 | 0 | 0 | ||
GE | Common | 369604103 | 5,372 | 84,375 | SH | SOLE | 84,375 | 0 | 0 | ||
Newmont | Common | 651639106 | 3,878 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
IGM Bioscience | Common | 449585108 | 991 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
Organon | Common | 68622V106 | 1,079 | 31,970 | SH | SOLE | 31,970 | 0 | 0 | ||
Mannkind | Common | 56400P706 | 743 | 195,073 | SH | SOLE | 195,073 | 0 | 0 | ||
Merck | Common | 589331107 | 29,511 | 323,700 | SH | SOLE | 323,700 | 0 | 0 | ||
Paratek | Cv 4.75% | 699374AA2 | 14,276 | 16,600,000 | PRN | SOLE | 16,600,000 | 0 | 0 | ||
Paratek | Common | 699374302 | 3,005 | 1,557,312 | SH | SOLE | 1,557,312 | 0 | 0 | ||
Pfizer | Common | 717081103 | 28,453 | 542,700 | SH | SOLE | 542,700 | 0 | 0 | ||
RLI | Common | 749607107 | 279 | 2,400 | SH | SOLE | 2,400 | 0 | 0 | ||
Supernus | Common | 868459108 | 5,844 | 202,105 | SH | SOLE | 202,105 | 0 | 0 | ||
Viatris | Common | 92556V106 | 644 | 61,512 | SH | SOLE | 61,512 | 0 | 0 | ||
Bausch Health | Common | 91911K102 | 11,531 | 1,381,000 | SH | SOLE | 1,381,000 | 0 | 0 | ||
XM Sirius | Common | 82968B103 | 4,645 | 757,843 | SH | SOLE | 757,843 | 0 | 0 | ||
XEL Energy | Common | 98389B100 | 29,188 | 412,500 | SH | SOLE | 412,500 | 0 | 0 |